Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2020 Mar 5;15(3):e0229909. doi: 10.1371/journal.pone.0229909

Induction of competent cells for Agrobacterium tumefaciens-mediated stable transformation of common bean (Phaseolus vulgaris L.)

Guo-qing Song 1,*, Xue Han 1, Andrew T Wiersma 2, Xiaojuan Zong 1, Halima E Awale 2, James D Kelly 2
Editor: Jen-Tsung Chen3
PMCID: PMC7058285  PMID: 32134988

Abstract

Stable transformation of common bean (Phaseolus vulgaris L.) has been successful, to date, only using biolistic-mediated transformation and shoot regeneration from meristem-containing embryo axes. In this study, using precultured embryo axes, and optimal co-cultivation conditions resulted in a successful transformation of the common bean cultivar Olathe using Agrobacterium tumefaciens strain EHA105. Plant regeneration through somatic embryogenesis was attained through the preculture of embryo axes for 12 weeks using induced competent cells for A. tumefaciens-mediated gene delivery. Using A. tumefaciens at a low optical density (OD) of 0.1 at a wavelength of 600 nm for infection and 4-day co-cultivation, compared to OD600 of 0.5, increased the survival rate of the inoculated explants from 23% to 45%. Selection using 0.5 mg L-1 glufosinate (GS) was effective to identify transformed cells when the bialaphos resistance (bar) gene under the constitutive 35S promoter was used as a selectable marker. After an 18-week selection period, 1.5% -2.5% inoculated explants, in three experiments with a total of 600 explants, produced GS-resistant plants through somatic embryogenesis. The expression of bar was confirmed in first- and second-generation seedlings of the two lines through reverse polymerase chain reaction. Presence of the bar gene was verified through genome sequencing of two selected transgenic lines. The induction of regenerable, competent cells is key for the successful transformation, and the protocols described may be useful for future transformation of additional Phaseolus germplasm.

Introduction

Common bean (Phaseolus vulgaris L.) is a member of the legume family Fabaceae. It is one of the most important grain legumes for direct consumption in human diets due to its unique nutritional profile and superior health benefits [14]. In response to increasing demands for food caused by the growing population, a fundamental goal of common bean breeding has been to develop high-yielding cultivars with desirable consumer traits [5]. A summary of the broad breeding objectives in common bean improvement was recently reviewed by Assefa [6]. Abundant genetic diversity, easy germplasm accessibility, and application of marker assisted breeding technologies have supported conventional bean breeding efforts [3, 7, 8]. In addition, advances in whole genome sequencing and transcriptome analysis have paved a way for genomics-enabled bean breeding through either conventional approaches or genetic engineering [911].

Genetic engineering is a powerful tool to introduce genes from sources that are inaccessible through sexual hybridization [1214]. Thus, substantial efforts have been made to develop reliable transformation methods for engineering common beans with various traits [13, 1521]. To date, no genetically engineered (GE) common bean has been commercialized, despite of the regulatory approval for the transgenic “Embrapa 5.1” common bean for golden mosaic virus (BGMV) resistance in Brazil in 2011 [2224]. An efficient and reproducible transformation system for the production of stable transgenic common bean plants is still lacking. The primary limitation has been recalcitrance of common bean genotypes to in vitro regeneration from non-meristem containing tissues [16, 25, 26].

Stable transformation of common bean at low frequencies (< 1%) has been achieved using particle bombardment-mediated transformation of meristematic tissues for different goals [11, 27, 28]. Agrobacterium tumefaciens-mediated transformation is desirable for common bean transformation because of its accessibility and tendency to produce low- or single-copy insertion(s) of the transgene [18]. To date, A. tumefaciens-mediated transformation of common bean has been studied extensively but has been met with limited success [16, 25]. We have been working on common bean regeneration and transformation since 2008. The main focus of this study was to develop a protocol for stable transformation of common bean using A. tumefaciens. The primary issue that arise from transformation of meristem-containing embryo axes is chimeric tissues; and it is difficult to produce a stable transgenic plant from a single transformed cell in T0 generation [2931]. In contrast, in this study, preculture of embryo axes induced competent cells for A. tumefaciens-mediated gene delivery and for nonchimeric regeneration through somatic embryogenesis. This is the key for production of stable transgenic pinto bean using A. tumefaciens in this study. The protocol described here has a potential application for transformation of other large seeded legumes, for which regenerable cells are limited to those from meristem-containing embryo axes (Fig 1).

Fig 1. Schematic representation of A. tumefaciens-mediated transformation of ‘Olathe’ pinto bean using competent cells induced from embryo axes.

Fig 1

Materials and methods

Plant materials and explant preparation

‘Olathe’ pinto bean (Phaseolus vulgaris L.) was used in this study due to its high efficiency in shoot production from mature embryo axes in our previous test (unpublished data). Between 200 and 300 mature, dry seeds were surface-sterilized with 2% sodium hypochlorite with gently shaking for 10 min in a 500 ml PYREX® media bottle (Corning, NY, USA) and followed by four rinses with sterile distilled water. The seeds were transferred to 4 or 5 Petri dishes (100 x15 mm) and each had one layer of seeds. Sterile distilled water, 30 ml/dish, was added to soak the seeds overnight at room temperature. All imbibed seeds were transferred to a sterile 500 ml PYREX® media bottle, where the seeds were washed three times with sterile distilled water prior to transferring to Petri dishes (100 x15 mm) for embryo axes extraction.

The seed coat was removed, and two types of explants were initially prepared after removing one cotyledon along the hilum using a sterile scalpel blade. A half-seed explant was prepared by removing the seed coat, radicle, or one cotyledon. Embryo axes explants were obtained by cutting off all cotyledons, radicles, and leaflets. To avoid potential cross-contamination, one set of sterile cutting tools (i.e., a scalpel, a cutting board, and a pair of forceps) were used to excise no more than 5 seeds. Both half-seed explants and embryo axes were cultured for 5 days on Murashige and Skoog (1962) medium (MS) [32]. Sterile explants were used for transformation (Fig 1).

Preculture of embryo axes was conducted on 30 ml regeneration medium [RM: MS + 44.4 μM 6-benzyl-aminopurine (BAP) + 2.27 μM thidiazuron (TDZ)] in each Petri dish (100 x15 mm). Subculture of the axes to fresh RM was performed every three weeks (Fig 1). All shoots from the axes were removed using a sterile scalpel blade prior to each subculture. After 12 weeks, each precultured embryo axes was cut into 4 to 8 explants for transformation. All in vitro materials were placed at 25 °C under a 16 h photoperiod of 30 μmol m-2s-1 unless indicated otherwise. Both MS and RM media contained MS salts and vitamins, 3% sucrose, pH was adjusted to 5.6, and solidified with 0.6% (w/v) agar. When acetosyringone, antibiotics, and glufosinate (GS) were used, they were filter-sterilized through 0.22 μm Millex®-GV filters (Millipore Corporation, Billerica, MA, USA) and added to media cooled to 50–60 °C after autoclaving.

Plasmid and Agrobacterium strain

The binary vector pDHB321.1 contains only the bialaphos resistance (bar) gene under the constitutive 35S promoter in its transfer DNA region. The vector was transferred into A. tumefaciens strain EHA105 [33]. Expression of the bar gene conferring to glufosinate herbicide-resistance has been demonstrated previously in transgenic celery and blueberry plants [34, 35].

To prepare A. tumefaciens culture, a single colony of EHA105:pDHB321.1 was cultured in 10 mL liquid yeast extraction broth (YEB) [36] containing 100 mg L-1 kanamycin monosulfate at 28 °C with constant shaking for 48 h. Thirty μL of the culture were then inoculated into 15 mL of the same medium and grown to an OD600 of 0.8–1.0. Before transformation, the culture was centrifuged at 2500 ×g for 5 min. The bacterial pellet was resuspended to an OD600 of 0.1 or 0.5 in liquid RM containing 100 μM acetosyringone.

Transformation experiments

Explants were transferred to a 50 ml Corning tube. EHA105:pDHB321.1 suspension in liquid RM containing 100 μM acetosyringone were added to the Corning tube and the explants were inoculated for 2 min at room temperature. After inoculation, the suspension cells were poured off and the infected explants were transferred onto two layers of sterile filter paper in a Petri dish, where the explants were blotted dry. The explants were then placed on one layer of sterile filter paper overlaid on 25 ml RM containing 100 μM acetosyringone in a Petri dish. Co-cultivation was carried out for 4 d at 25 °C in the dark (Fig 1).

After co-cultivation, all explants were transferred into a 50 ml Corning tube and rinsed five times, 1 min per time, in liquid RM. The sixth wash was conducted in liquid RM containing 500 mg L-1 timentin (Tn) and 500 mg L-1 cefotaxime (Cef) for 3 min. Three selection media were used in the whole selection process (Fig 1). The washed explants were blotted dry on sterile filter paper in a Petri dish and place on selection RM1 [SRM1: RM containing 0.1 mg L-1 GS, 250 mg L-1 Tn, and 250 mg L-1 Cef] and cultured for 3 wk. After 3 wk selection on RM1, the explants were subcultured to selection RM2 [SRM2: RM containing 0.2 mg L-1 GS, 250 mg L-1 Tn, and 250 mg L-1 Cef] and a subculture to fresh SRM2 was conducted after 3 wk. After a total of 6 wk selection on SRM2, the explants were transferred to selection RM3 (SRM3: RM containing 0.5 mg L-1 GS, 250 mg L-1 Tn, and 250 mg L-1 Cef). For each of the first three subcultures described (i.e., from SRM1 to SRM2, from SRM2 to SRM2, and from SRM2 to SRM3), all emerged shoots for any explants were removed. The fourth subculture was a direct transfer of the explants to fresh SRM3 without removing any emerged shoots. The fifth subculture was to transfer the shoots or plants to 30 ml selection MS containing 0.5 mg L-1 GS, 250 mg L-1 Tn, and 250 mg L-1 Cef in each 40 mm × 110 mm (diameter × height) glass jar for rooting. Shoots/plants from different explants were labelled separately. All subcultures were performed at 3 wk intervals.

Rooted GS-resistant plants were washed using tap water to remove any agar attached to the roots, each individual plant was then planted in water-soaked Suremix Perlite planting medium (Michigan Grower Products Inc., Galesburg, MI) in a 4-inch plastic pot (8.9 cm width × 12.7 cm height). Each pot was enclosed in a zipped one-gallon zip bag to keep moisture for one week. The bags were open progressively in one week. The survived plants were repotted to clay pot (22 cm width × 19 cm height). The plants were grown at 23–25 °C under a 16 h photoperiod of 55 μmol m-2s-1 and were watered and fertilized as needed to harvest T1 seeds.

Following the protocols described, four transformation experiments were conducted to evaluate the effect of explant types and Agrobacterium concentrations on stable transformation. In the first experiment, half-seed explants and embryo axes explants were inoculated with EHA105:pDHB321.1 suspension at OD600 of 0.1 and 0.5 for each type of explants. In the rest three experiments, EHA105:pDHB321.1 suspension at OD600 of 0.1 was used. In the second experiment, both embryo axes and precultured embryo axes were inoculated. In the third experiment, only precultured embryo axes were infected to validate the best approach observed in the second experiment. Finally, in the fourth experiment, all three types of explants were used to compare different approaches at the same time; meanwhile, uninoculated explants, 60–90 for each type, were used as control to test their regeneration under the selection conditions.

Phenotyping of T1 and T2 plants

Three T1 seeds of transgenic line #1 and four T1 seeds of transgenic line #2, one for each clay pot (22 cm width × 19 cm height), were sown. T1 plants were grown in a growth chamber from March to June 2018. The growth chamber was set to 14 h photoperiod with 26/22 °C day and night temperature, respectively. Nontransgenic plants were used as a control. Plant growth was documented by taking pictures of the plants periodically. Self-pollinated T2 seeds from each T1 plant were harvested separately. Six T2 seeds from each of the seven T1 plants were grown in the greenhouse from July to October 2018 to bulk seeds.

Molecular analysis

Genomic DNA from various tissues, i.e., T0 leaf, T0 root, and T1 leaf, was isolated using a cetyl trimethyl ammonium bromide (CTAB) method. Non-transgenic leaf and root were used as controls. A pair of primers, 35S_F: 5’-TGA CGC ACA ATC CCA CTA TC-3’ and Bar_R1: 5’-GAA GTC CAG CTG CCA GAA AC-3’, was used in a regular polymerase chain reaction (PCR) analysis for amplifying a 400-base pair (bp) fragment.

Total RNA was isolated from leaves of T1 plants using the RNeasy Mini Kit (Qiagen, Valencia, CA, USA). All RNA samples were treated by DNase. PCR analysis of the RNA samples using 35S_F and Bar_R1 primers were conducted to detect the potential DNA contamination. Nontransgenic leaf and root were used as controls. Reverse transcription of RNA to complementary DNA (cDNA) was performed using SuperScript II reverse transcriptase (Invitrogen, Carsbad, CA, USA). 25–50 ng cDNA per reaction was used for reverse transcription (RT) PCR reactions. A pair of primers to amplify the full length of a 552 bp fragment, Bar_F: 5’-ATG AGC CCA GAA CGA CGC C-3’ and Bar_R: 5’-TCA GAT CTC GGT GAC GG-3’, was used for RT-PCR analysis. PCR conditions for both regular PCR and RT-PCR consisted of an initial denaturation at 94 °C for 2 min, followed by 30 cycles of 94 °C for 40 sec, 58 °C for 1.5 min, and 72 °C for 1.5 min, followed by a final extension at 72 °C for 10 min.

The DNA samples from one T0 plant of the transgenic line 1, one T1 plant of transgenic line 2, and one nontransgenic plant were purified for sequencing using the DNeasy Plant Mini Kit (Qiagen, Valencia, CA). Three samples were sequenced for 150-bp pair end reads (Illumina HiSeq 4000) with about 45-fold common bean genome coverage at the Research Technology Support Facility at Michigan State University [10]. ABySS/2.1.5 (k = 96) were used to assemble genome sequences using the resources at the High Performance Computing Center at Michigan State University [37]. The full length of the 35S-bar plus the nos terminator sequence was used to search three assembled genome databases for the bar insertion using nucleotide Basic Local Alignment Search Tool (BLAST) [38].

Results

Induction of competent cells for common bean regeneration

Sterile embryo axes of ‘Olathe’ pinto bean produced an average of 3.6 shoots per explant after 4-week culture, whereas no regeneration occurred from leaf explants (Fig 2A and 2B). Interestingly, continuous removal of any shoots from embryo axes stimulated production of more callus-like green buds from all explants in 6–8 weeks (Fig 2C and 2D). These tiny buds can continue to proliferate during the subcultures on RM, thus providing an efficient approach to produce more buds. More importantly, these green buds were regenerable after they were transferred to MS medium. The tiny regenerable callus-like tissues obtained through preculturing embryo axes are desirable explants for transformation due to the increased number of competent cells for regeneration (Fig 2C and 2D). Each precultured embryo axes provided 4–8 regenerable callus-like explants for stable transformation; meanwhile, these precultured embryo axes can be subcultured and used for transformation even after 12 weeks.

Fig 2. Induction of competent cells from embryo axes for efficient regeneration of ‘Olathe’ pinto bean.

Fig 2

(A) Surface sterilized and soaked seeds for explant preparation. (B) Shoot production from embryo axes after 4-week culture on RM1, on which leaf explants did not survive. A. tumefaciens-mediated transformation of ‘Olathe’ pinto bean. (C, D) Embryo axes after 12-week preculture on RM. All shoots were removed during the subcultures in order to promote callus and bud formation. Bars = 1 cm.

Low Agrobacterium concentration increases explants survival rate after infection and co-cultivation

In experiment 1, we tested both half-seed explants and embryo axes explants, two commonly used explants for legume, to evaluate EHA105:pDHB321.1 cell suspension at OD600 of 0.1 and 0.5 for infection without agroinfiltration. For each of the two explant types, the OD600 of 0.1 resulted in doubling explants survival rates compared to the OD600 of 0.5 after 6-week selection (Table 1). The result suggests that a lower Agrobacterium concentration of OD600 of 0.1 can reduce explant death and is preferable to OD600 of 0.5 for infection. Thus, EHA105:pDHB321.1 suspension at OD600 of 0.1 was chose to use for stable transformation in the rest of the experiments. No GS-resistant whole plants were generated in the experiment 1 (Table 1).

Table 1. Summary of three transformation experiments of common bean ‘Olathe’.

Explants Infection Number of inoculated explants Number (percentage) of explants survived after 6-week of selection Number of GS resistant shoots after 12-week selection Number of GS resistant plants after 18-week selection Transformation frequency
Experiment 1
Half-seed explants OD600 of 0.1 65 26 (40.0%) 1 0 0
OD600 of 0.5 63 12 (19.0%) 0 0 0
Embryo axes OD600 of 0.1 92 43 (46.7%) 3 1 1.1%
OD600 of 0.5 87 20 (23.0%) 1 0 0
Experiment 2
Embryo axes OD600 of 0.1 200 84 (42.0%) 8 1 0.5%
Pre-cultured embryo axes OD600 of 0.1 200 102 (51%) 6 4 2%
Experiment 3
Pre-cultured embryo axes OD600 of 0.1 200 90 (45%) 4 3 1.5%
Experiment 4
Half-seed explants OD600 of 0.1 100 33 (33.0%) 2 0 0
Embryo axes OD600 of 0.1 200 89 (44.5%) 7 1 0.5%
Pre-cultured embryo axes OD600 of 0.1 200 112 (56.0%) 8 5 2.5%

Selection and regeneration of transgenic plants

Four-day co-cultivation after the infection using EHA105:pDHB321.1 suspension at OD600 resulted an effective control of over-growth of the EHA105:pDHB321.1 during cocultivation and selection, respectively, for all of three explant types (Fig 3A and 3B). A gradual increase of GS from 0.1 to 0.5 mg/L was effective in selecting transformed cells; meanwhile, it prevented the elimination of transformed cells by a high GS content before enough GS-resistance was developed (Fig 3B–3D). All shoots induced from embryo axes and half-seed explants within one-month selection using 0.1 mg/L GS turned white completely or partially after they were selected on RM3 containing 0.5 mg/L GS (Fig 3C), suggesting these early formed shoots were either escapes or chimeric. The result is consistent with the previous report in which early formed shoots following the transformation of the gusA reporter were either escapes or chimeric due to the none or partial GUS-staining [16]. This is reasonable because there was a very low possibility of plant/shoot formation from a single transformed cell of common bean within 4-weeks. Even in the model plant tobacco (Nicotiana tabacum), transgenic shoots are usually produced after 6-week selection. Thus, removing all the shoots formed within the first 12-week of selection was conducted to minimize production of the chimeric transformants in this study. After a total of 18-weeks of selection, no GS-resistant plants were obtained from the 165 inoculated half-seed explants inoculated in experiments 1 and 4. One GS-resistant plant was produced for each of the three experiments (Table 1).

Fig 3. A. tumefaciens-mediated transformation of ‘Olathe’ pinto bean.

Fig 3

(A) Explants after 4-day co-cultivation in the dark at 25 °C. (I, II) Half-seeds explants. (III) Precultured embryo axes explants. (IV) Embryo axes explants. (B) Precultured embryo axes explants after 3-week selection on selection RM1. (C) Embryo axes explants after 6-week selection on selection RM3. (D, E) GS-resistant calli and green buds induced from the precultured embryo axes explants after 6-week selection on selection RM3. (F) Rooting of the GS-resistant plants produced from the precultured embryo axes explants. Bars = 1 cm.

In contrast to embryo axes and half-seed explants, precultured embryo axes explants did not produce many big shoots during the whole GS-selection process (Fig 3B). After 12-week selection, green bud- or somatic embryo-like regenerants were produced on selection RM3 (Fig 3D and 3E). These regenerants rooted on selection MS containing 0.5 mg L-1 GS (Fig 3F). The overall selection, regeneration, and rooting process took 18 to 20 weeks and the frequencies of GS-resistant plants for three transformation frequencies were 2%, 1.5%, and 2.5%, because no rooted GS-resistant plants were produced from the uninoculated explants. The results of the three transformation experiments suggest that the protocol is reliable for a successful transformation although the transformation frequencies were not high. Apparently, the precultured embryo axes can produce more regenerable competent cells for transformation and regeneration through somatic embryogenesis (Fig 2C); consequently, these regenerable competent cells, unlike the other explants used in either this study or in literatures, are key for the successful transformations in this study (Table 1).

Production of T1 seeds and T2 seeds

The main focus of this study was to develop transformation protocols, thus, effort with three experimental repeats (i.e., experiments 2–4) was made to verify that successful transformations using precultured embryo axes explants were repeatable (Table 1). After the success in experiment 4, the first three rooted T0 transgenic lines were transplanted to soil and easily survived. However, none of them set seeds due probably to overwatering. Subsequently, two additional transgenic lines were planted (Fig 4A and 4B), five and six T1 seeds were obtained from transgenic line 1 and 2, respectively.

Fig 4. Rooting of T0 ‘Olathe’ pinto bean and T1 seed production.

Fig 4

(A) Rooting of GS-resistant plants on selection MS. (B) Production of T1 seeds at 23–25 °C under a 16 h photoperiod of 55 μmol m-2s-1.

Three and four T1 seeds for transgenic line 1 and 2, respectively, were planted in the greenhouse to bulk T2 seeds (Fig 5A and 5B). All T1 plants were grown normally and produced T2 seeds (Fig 5C and 5D).

Fig 5. T1 plants and T2 seeds.

Fig 5

(A, B) T1 plants of two transgenic lines of ‘Olathe’ pinto bean. Except 2–1*, all the other plants are RT-PCR-positive for the bar gene. (C) Seeds from transgenic 1–1 and nontransgenic (NT) 2–1 and NT plants.

Molecular analysis of T0 and T1 plants

PCR analysis was conducted using DNA samples isolated from both leaf and root tissues of all 15 T0 transgenic plants produced on selection MS containing 0.5 mg L-1 GS after 18 to 20 weeks across all four experiments. Thirty DNA samples from the 15 T0 transgenic plants obtained in four experiments were PCR positive for the presence bar gene, whereas all eight DNA samples of nontransgenic leaf and root were PCR-negative for the bar gene. The result indicated that the GS-resistant plants contained transgenic cells in both leaf and root tissues. Based on the PCR results, the transformation frequencies in three experiments using embryo axes as explants were 1.1%, 0.5%, and 0.5%; and the transformation frequencies using precultured embryo axes were 2%, 1.5%, and 2.5%. Apparently, the precultured embryo axes led to higher transformation frequencies than the embryo axes likely due to the increased number of competent cells for transformation and regeneration in each explant.

Whether or not chimeric plants are produced, an effective transformation method for seed crops must result in the development of transgenic T1 seeds, from which homozygous progeny can be identified and advanced. In this study, a total of seven T1 plants, 3 and 4 for each of the two transgenic lines, were analyzed through PCR using the 35S_F and the Bar_R1 primers. Presence of the 400-bp fragment of the bar gene was observed in all three plants derived from transgenic line #1 and 3 out of 4 plants derived from transgenic line #2; in contrast, no fragment was detected in nontransgenic controls. The results suggested that the bar gene was present in six PCR-positive T1 plants. Similarly, expression of the bar gene was verified in all six PCR-positive T1 plants through RT-PCR using genomic DNA-free cDNA and the Bar_F and Bar_R primers (Fig 6). The PCR and RT-PCR results were consistent for the T1 plants. The repeated success of utilizing precultured embryo axes as explants demonstrates the reliability of this transformation protocol for the pinto bean variety Olathe.

Fig 6. RT-PCR analysis of bar expression in leaves of T1 transgenic and nontransgenic (NT) plants of ‘Olathe’ pinto bean.

Fig 6

M: size ladder.

Whole genome sequencing was conducted using DNA samples from a non-transgenic plant and two transgenic lines, including one T0 sample of transgenic line 1 and one T1 sample from transgenic line #2. In the assembled genome sequences for both transgenic lines, the contigs containing the 35S-bar gene were present; in contrast, the 35S-bar gene was not detected in non-transgenic plant. In the T1 transgenic plant, two contigs included a total of 91% of the sequence of the bar gene (Fig 7A and 7B). In the T0 transgenic plant of the transgenic line #1, 500 contigs each contained 123–278 bp sequences aligned to the regions dispersed across the whole bar gene (S1 Table); surprisingly, some of these contigs had sequence overlaps but were not assembled into longer contigs, which may be a limitation of the de novo sequence assembly approach. Based on the detected transgene contigs in the assembled genomes, it was likely that the transgenic line #2 had one-copy insertion and transgenic line #1 had multiple copies, although the insertion position(s) could not be identified. When pRiA4 sequence in the backbone region of pDHB32.1 was used to BLAST against the assembled genomes (Fig 7A and 7C), the pRiA4 was detected in both the non-transgenic and the T0 transgenic plants; in contrast, a portion of the pRiA4 (3,169 out of 8,917 bp, e-value = 0) near the left border of the transfer DNA (T-DNA) was detected in the genome of the T1 transgenic plant (Fig 7C). Additionally, sequences showed high similarities to the KanR gene were not detected in the assembled genomes of any non-transgenic and transgenic lines. Apparently, an integration of a partial of the non-T-DNA pRiA4 occurred in the T1 transgenic plant. If the detected transgene sequences were due to the residual of EHA105:pDHB321.1, we should have detected the KanR gene sequences in the transgenic lines (Fig 7A). The results verify the stable transformation of the 35S-bar in the two transgenic lines for the first time using whole genome sequencing.

Fig 7. Stable integration of the transgenes confirmed by genome sequencing of a T1 transgenic plant of the transgenic line #2.

Fig 7

(A) Schematic representation of the binary vector pDHB321.1. (B) Detection of the bar in the T-DNA region. (C) Detection of the pRiA4 sequence in the backbone region of the pDHB321.1.

Discussions

Meristem tissues are a reliable source of regenerable calli

Meristem-containing tissues remain the major regenerable explants for stable transformation of grain legumes, such as cotyledonary node or embryo axes for soybean (Glycine max (L.) Merr.) [39, 40], common bean [41], and cowpea (Vigna unguiculata L. Walp) [42]. In our efforts to induce shoots from the embryo axes of common bean cultivars, all of the five cultivars tested were able to produce multiple shoots [43], suggesting that the meristem tissues are amenable to shoot production either through proliferation of the original meristems or through new shoot organogenesis from the undifferentiated cells adjacent to the meristems. If new shoot organogenesis did occur, we hypothesized that a preculture of embryo axes on RM and continuous removal of any shoots from embryo axes would induce more cells that are amenable for both A. tumefaciens-mediated transgene(s) delivery and plant regeneration. This hypothesis was tested in a preliminary experiment using embryo axes of Olathe’ pinto bean. We found that a 10-week culture of the embryo axes resulted in desirable cells similar to those in Fig 2C and 2D. The preliminary results laid the foundation of this research. Because recalcitrance of common bean genotypes to in vitro regeneration from non-meristem containing tissues is the primary limitation for stable transformation [16, 25, 26], the preculture method described for the Olathe’ pinto bean may facilitate transformation of the other common bean cultivars. In fact, it has been reported that the EHA105-mediated transformation of primary and proliferative calli of common bean cv. CIAP7247F resulted in transgenic plants [20].

A. tumefaciens-inoculation induces explants death

High concentrations of A. tumefaciens, agroinfiltration and a long cocultivation time enhanced transient expression of an intron-interrupted gusA in common bean cultivars [16]. However, in stable transformations, we previously found that the agroinfiltration using EHA105:pDHB321.1 suspension at OD600 of 0.5 caused death of 70% of embryo axes explants in two weeks after co-cultivation under even a non-selection condition (unpublished data). Apparently, excessive A. tumefaciens infection through agroinfiltration could be responsible for explant death. Similarly, in the failure of our previous efforts in producing stable transgenic plants, the default inoculation conditions adapted from the other crops using EHA105 at OD600 of 0.5–0.8 and 4-day co-cultivation led to unusual high death percentages (20%-50%) of the inoculated explants under effective controls of A. tumefaciens growth after co-cultivation. In these cases, we believed that the high EHA105 cell concentrations could be responsible for the death of the explants due to the lack of any other more reasonable explanation. Thus, the low EHA105 concentration at OD600 of 0.1 was tested, and the results demonstrated that low EHA105 concentration contributed the successful transformations in this study (Table 1).

Effectiveness of whole genome sequencing for stable transformation confirmation

When meristems were used as explants for common bean transformation, it is very common that chimeric transformants can be produced [43]. To verify the stable transgenic lines, Southern blot analysis of T1 plants are often used. Alternatively, we found that whole genome sequencing was an effective approach to confirm stable transformations [44, 45]. In this study, although the assembled sequencing data did not allow us to determine the copy number as well as the insertion position, the detected T-DNA sequences verified the stable integration of the transgenes (Fig 7). To our knowledge, this is the first stable transgenic common bean obtained through A. tumefaciens-mediated transformation and confirmed by whole genome sequencing.

Conclusions

We obtained stable transgenic common bean through A. tumefaciens-mediated transformation. We found that the induction of competent cells prior to the infection and a low Agrobacterium concentration for infection and co-cultivation was important in our success in stable transformation. The stable transformation was verified through whole genome sequencing of the transgenic plants. This protocol has potential to be used for transformation of other important legume crops.

Supporting information

S1 Table. Identification of transgene inserts using 35S-bar as a query BLASTN against the assembled genome of the T0 plant of transgenic line #1.

(XLSX)

S1 Fig

(TIF)

Data Availability

All relevant data are within the paper and its Supporting Information files.

Funding Statement

The authors received no specific funding for this study.

References

  • 1.Hayat I, Ahmad A, Masud T, Ahmed A, Bashir S. Nutritional and health perspectives of beans (Phaseolus vulgaris L.): an overview. Crit Rev Food Sci Nutr. 2014;54(5):580–92. Epub 2013/11/23. 10.1080/10408398.2011.596639 . [DOI] [PubMed] [Google Scholar]
  • 2.Hacisalihoglu G, Settles AM. Natural Variation in Seed Composition of 91 Common Bean Genotypes and Their Possible Association with Seed Coat Color. J Plant Nutr. 2013;36(5):772–80. 10.1080/01904167.2012.754041 [DOI] [Google Scholar]
  • 3.Rivera A, Plans M, Sabate J, Casanas F, Casals J, Rull A, et al. The Spanish Core Collection of Common Beans (Phaseolus vulgaris L.): An Important Source of Variability for Breeding Chemical Composition. Front Plant Sci. 2018;9:1642 Epub 2018/11/30. 10.3389/fpls.2018.01642 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Broughton WJ, Hernandez G, Blair M, Beebe S, Gepts P, Vanderleyden J. Beans (Phaseolus spp.)—model food legumes. Plant Soil. 2003;252(1):55–128. 10.1023/A:1024146710611 [DOI] [Google Scholar]
  • 5.Kelly JD. Developing improved varieties of common bean In: Sivasankar S, Bergvinson D, Gaur P, Agrawal SK, Beebe S, Tamò M, editors. Achieving sustainable cultivation of grain legumes Vol 2: Improving cultivation of particular grain legumes 2. Cambridge UK: Burleigh Dodds Science Publishing; 2018. p. 3–17. [Google Scholar]
  • 6.Assefa T, Mahama AA, Brown AV, Cannon EKS, Rubyogo JC, Rao IM, et al. A review of breeding objectives, genomic resources, and marker-assisted methods in common bean (Phaseolus vulgaris L.). Mol Breeding. 2019;39(2) ARTN 20 10.1007/s11032-018-0920-0 [DOI] [Google Scholar]
  • 7.Kelly JD, Bornowski N. Marker assisted breeding for economic traits in common bean In: Gosal SS, Wani SH, editors. Biotechnologies of Crop Improvement: Volume 3: Genomic Approaches 3. Cham, Switzerland: Springer; 2018. p. 211–38. [Google Scholar]
  • 8.Raatz B, Mukankusi C, Lobaton JD, Male A, Chisale V, Amsalu B, et al. Analyses of African common bean (Phaseolus vulgaris L.) germplasm using a SNP fingerprinting platform: diversity, quality control and molecular breeding. Genetic Resources and Crop Evolution. 2019;66(3):16 10.1007/s10722-019-00746-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Kamfwa K, Zhao D, Kelly JD, Cichy KA. Transcriptome analysis of two recombinant inbred lines of common bean contrasting for symbiotic nitrogen fixation. Plos One. 2017;12(2):e0172141 Epub 2017/02/14. 10.1371/journal.pone.0172141 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Schmutz J, McClean PE, Mamidi S, Wu GA, Cannon SB, Grimwood J, et al. A reference genome for common bean and genome-wide analysis of dual domestications. Nat Genet. 2014;46(7):707–13. 10.1038/ng.3008 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Bonfim K, Faria JC, Nogueira EOPL, Mendes EA, Aragao FJL. RNAi-mediated resistance to Bean golden mosaic virus in genetically engineered common bean (Phaseolus vulgaris). Mol Plant Microbe In. 2007;20(6):717–26. 10.1094/Mpmi-20-6-0717 [DOI] [PubMed] [Google Scholar]
  • 12.Christou P. Biotechnology applied to grain legumes. Field Crop Res. 1997;53(1–3):83–97. 10.1016/S0378-4290(97)00024-5 [DOI] [Google Scholar]
  • 13.Dita MA, Rispail N, Prats E, Rubiales D, Singh KB. Biotechnology approaches to overcome biotic and abiotic stress constraints in legumes. Euphytica. 2006;147(1–2):1–24. 10.1007/s10681-006-6156-9 [DOI] [Google Scholar]
  • 14.Svetleva D, Velcheva M, Bhowmik G. Biotechnology as a useful tool in common bean (Phaseolus vulgaris L.) improvement. Euphytica. 2003;131(2):189–200. 10.1023/A:1023983831582 [DOI] [Google Scholar]
  • 15.Rivera NGR, Garcia-Salinas C, Aragao FJL, de la Garza RID. Metabolic engineering of folate and its precursors in Mexican common bean (Phaseolus vulgaris L.). Plant Biotechnol J. 2016;14(10):2021–32. 10.1111/pbi.12561 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Mukeshimana G, Ma YM, Walworth AE, Song GQ, Kelly JD. Factors influencing regeneration and Agrobacterium tumefaciens-mediated transformation of common bean (Phaseolus vulgaris L.). Plant Biotechnology Reports. 2013;7(1):59–70. 10.1007/s11816-012-0237-0 [DOI] [Google Scholar]
  • 17.Barraza A, Coss-Navarrete EL, Vizuet-de-Rueda JC, Martinez-Aguilar K, Hernandez-Chavez JL, Ordaz-Ortiz JJ, et al. Down-regulation of PvTRX1h increases nodule number and affects auxin, starch, and metabolic fingerprints in the common bean (Phaseolus vulgaris L.). Plant Sci. 2018;274:45–58. 10.1016/j.plantsci.2018.05.006 [DOI] [PubMed] [Google Scholar]
  • 18.Somers DA, Samac DA, Olhoft PM. Recent advances in legume transformation. Plant Physiol. 2003;131(3):892–9. Epub 2003/03/20. 10.1104/pp.102.017681 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Faria JC, Albino MMC, Dias BBA, Cancado LJ, da Cunha NB, Silva LD, et al. Partial resistance to Bean golden mosaic virus in a transgenic common bean (Phaseolus vulgar L.) line expressing a mutated rep gene. Plant Sci. 2006;171(5):565–71. 10.1016/j.plantsci.2006.06.010 [DOI] [Google Scholar]
  • 20.Collado R, Bermudez-Caraballoso I, Garcia LR, Veitia N, Torres D, Romero C, et al. Agrobacterium-mediated transformation of Phaseolus vulgaris L. using indirect organogenesis. Sci Hortic-Amsterdam. 2015;195:89–100. 10.1016/j.scienta.2015.06.046 [DOI] [Google Scholar]
  • 21.Liu ZC, Park BJ, Kanno A, Kameya T. The novel use of a combination of sonication and vacuum infiltration in Agrobacterium-mediated transformation of kidney bean (Phaseolus vulgaris L.) with lea gene. Mol Breeding. 2005;16(3):189–97. 10.1007/s11032-005-6616-2 [DOI] [Google Scholar]
  • 22.Balsamo GM, Valentim-Neto PA, Mello CS, Arisi ACM. Comparative Proteomic Analysis of Two Varieties of Genetically Modified (GM) Embrapa 5.1 Common Bean (Phaseolus vulgaris L.) and Their Non-GM Counterparts. J Agr Food Chem. 2015;63(48):10569–77. 10.1021/acs.jafc.5b04659 [DOI] [PubMed] [Google Scholar]
  • 23.Souza TLPO, Faria JC, Aragao FJL, Del Peloso MJ, Faria LC, Wendland A, et al. Agronomic Performance and Yield Stability of the RNA Interference-Based Bean golden mosaic virus-Resistant Common Bean. Crop Sci. 2018;58(2):579–91. 10.2135/cropsci2017.06.0355 [DOI] [Google Scholar]
  • 24.Aragao FJL. GM plants with RNAi—golden mosaic resistant bean. BMC Proc. 2014;8(Suppl 4): O24. [Google Scholar]
  • 25.Solis-Ramose LY, Ortiz-Pavon JC, Andrade-Torres A, Porras-Murillo R, Angulo AB, de la Serna EC. Agrobacterium tumefaciens-mediated transformation of common bean (Phaseolus vulgaris) var. Brunca. Rev Biol Trop. 2019;67(2):83–94. [Google Scholar]
  • 26.Veltcheva M, Svetleva D, Petkova S, Perl A. In vitro regeneration and genetic transformation of common bean (Phaseolus vulgaris L.)—Problems and progress. Sci Hortic-Amsterdam. 2005;107(1):2–10. [Google Scholar]
  • 27.Kim JW, Minamikawa T. Transformation and regeneration of French bean plants by the particle bombardment process. Plant Sci. 1996;117(1–2):131–8. 10.1016/0168-9452(96)04403-2 [DOI] [Google Scholar]
  • 28.Ramirez Rivera NG, Garcia-Salinas C, Aragao FJ, Diaz de la Garza RI. Metabolic engineering of folate and its precursors in Mexican common bean (Phaseolus vulgaris L.). Plant Biotechnol J. 2016;14(10):2021–32. Epub 2016/03/22. 10.1111/pbi.12561 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Hnatuszko-Konka K, Kowalczyk T, Gerszberg A, Glinska S, Grzegorczyk-Karolak I. Regeneration of Phaseolus vulgaris from epicotyls and hypocotyls via direct organogenesis. Sci Rep. 2019;9(1):6248 Epub 2019/04/20. 10.1038/s41598-019-42723-8 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Hnatuszko-Konka K, Kowalczyk T, Gerszberg A, Wiktorek-Smagur A, Kononowicz AK. Phaseolus vulgaris—Recalcitrant potential. Biotechnol Adv. 2014;32(7):1205–15. 10.1016/j.biotechadv.2014.06.001 [DOI] [PubMed] [Google Scholar]
  • 31.Quintero-Jimenez A, Espinosa-Huerta E, Acosta-Gallegos JA, Guzman-Maldonado HS, Mora-Aviles MA. Enhanced shoot organogenesis and regeneration in the common bean (Phaseolus vulgaris L.). Plant Cell Tiss Org. 2010;102(3):381–6. 10.1007/s11240-010-9744-2 [DOI] [Google Scholar]
  • 32.Murashige T, Skoog F. A Revised Medium for Rapid Growth and Bio Assays with Tobacco Tissue Cultures. Physiol Plantarum. 1962;15(3):473–97. 10.1111/j.1399-3054.1962.tb08052.x [DOI] [Google Scholar]
  • 33.Hood EE, Gelvin SB, Melchers LS, Hoekema A. New Agrobacterium Helper Plasmids for Gene-Transfer to Plants. Transgenic Res. 1993;2(4):208–18. 10.1007/Bf01977351 [DOI] [Google Scholar]
  • 34.Loskutov AV, Song GQ, Sink KC. Evaluation of methods for celery (Apium Graveolens L.) transformation using Agrobacterium tumefaciens and the bar gene as selectable marker. In Vitro Cell Dev-Pl. 2008;44(4):239–45. 10.1007/s11627-008-9116-3 [DOI] [Google Scholar]
  • 35.Song GQ, Sink KC, Callow PW, Baughan R, Hancock JF. Evaluation of a herbicide-resistant trait conferred by the bar gene driven by four distinct promoters in transgenic blueberry plants. J Am Soc Hortic Sci. 2008;133(4):605–11. [Google Scholar]
  • 36.Vervliet G, Holsters M, Teuchy H, Vanmontagu M, Schell J. Characterization of Different Plaque-Forming and Defective Temperate Phages in Agrobacterium Strains. J Gen Virol. 1975;26(Jan):33–48. [DOI] [PubMed] [Google Scholar]
  • 37.Simpson JT, Wong K, Jackman SD, Schein JE, Jones SJ, Birol I. ABySS: a parallel assembler for short read sequence data. Genome Res. 2009;19(6):1117–23. Epub 2009/03/03. 10.1101/gr.089532.108 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.McGinnis S, Madden TL. BLAST: at the core of a powerful and diverse set of sequence analysis tools. Nucleic Acids Research. 2004;32(suppl_2):W20–W5. 10.1093/nar/gkh435 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Paz MM, Martinez JC, Kalvig AB, Fonger TM, Wang K. Improved cotyledonary node method using an alternative explant derived from mature seed for efficient Agrobacterium-mediated soybean transformation. Plant Cell Reports. 2006;25(3):206–13. 10.1007/s00299-005-0048-7 [DOI] [PubMed] [Google Scholar]
  • 40.Li SX, Cong YH, Liu YP, Wang TT, Shuai Q, Chen NN, et al. Optimization of Agrobacterium-Mediated Transformation in Soybean. Frontiers in Plant Science. 2017;8 ARTN 246 10.3389/fpls.2017.00246 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Aragao FJ, de Sa MF, Almeida ER, Gander ES, Rech EL. Particle bombardment-mediated transient expression of a Brazil nut methionine-rich albumin in bean (Phaseolus vulgaris L.). Plant Mol Biol. 1992;20(2):357–9. Epub 1992/10/01. 10.1007/bf00014508 . [DOI] [PubMed] [Google Scholar]
  • 42.Bett B, Gollasch S, Moore A, Harding R, Higgins TJV. An Improved Transformation System for Cowpea (Vigna unguiculata L. Walp) via Sonication and a Kanamycin-Geneticin Selection Regime. Front Plant Sci. 2019;10:219 Epub 2019/03/16. 10.3389/fpls.2019.00219 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Mukeshimana G, Ma Y, Walworth AE, Song G-q, Kelly JD. Factors influencing regeneration and Agrobacterium tumefaciens-mediated transformation of common bean (Phaseolus vulgaris L.). Plant Biotechnology Reports. 2012;7(1):59–70. 10.1007/s11816-012-0237-0 [DOI] [Google Scholar]
  • 44.Song G-Q, Chen Q. Overexpression of the MADS-box gene K-domain increases the yield potential of blueberry. Plant Sci. 2018;276:10 10.1016/j.plantsci.2018.07.018 [DOI] [PubMed] [Google Scholar]
  • 45.Song G-Q, Walworth A. An invaluable transgenic blueberry for studying chilling-induced flowering in woody plants. BMC Plant Biology. 2018;18:16. [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Jen-Tsung Chen

9 Jan 2020

PONE-D-19-35407

Induction of competent cells for Agrobacterium tumefaciens-mediated stable transformation of common bean (Phaseolus vulgaris L.)

PLOS ONE

Dear Dr Song,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

We would appreciate receiving your revised manuscript by Feb 23 2020 11:59PM. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter.

To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). This letter should be uploaded as separate file and labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. This file should be uploaded as separate file and labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. This file should be uploaded as separate file and labeled 'Manuscript'.

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

We look forward to receiving your revised manuscript.

Kind regards,

Jen-Tsung Chen, Ph.D.

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at http://www.journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and http://www.journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2.  PLOS ONE now requires that authors provide the original uncropped and unadjusted images underlying all blot or gel results reported in a submission’s figures or Supporting Information files. This policy and the journal’s other requirements for blot/gel reporting and figure preparation are described in detail at https://journals.plos.org/plosone/s/figures#loc-blot-and-gel-reporting-requirements and https://journals.plos.org/plosone/s/figures#loc-preparing-figures-from-image-files. When you submit your revised manuscript, please ensure that your figures adhere fully to these guidelines and provide the original underlying images for all blot or gel data reported in your submission. See the following link for instructions on providing the original image data: https://journals.plos.org/plosone/s/figures#loc-original-images-for-blots-and-gels.

In your cover letter, please note whether your blot/gel image data are in Supporting Information or posted at a public data repository, provide the repository URL if relevant, and provide specific details as to which raw blot/gel images, if any, are not available. Email us at plosone@plos.org if you have any questions.

3. PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager. Please see the following video for instructions on linking an ORCID iD to your Editorial Manager account: https://www.youtube.com/watch?v=_xcclfuvtxQ

4. Thank you for stating the following in the Acknowledgments Section of your manuscript:

'This research was primarily supported by Michigan State University through a Project GREEEN grant for infrastructure of the Plant Biotechnology Resource & Outreach Center.'

We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form.

Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows:

'The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.'

Additional Editor Comments (if provided):

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: N/A

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The paper should be deeply revised the structure of the paper according to Plos one instruction (“Results and discussions” should divided into results section and discussions section). In particular the Discussion section should be completely rewritten, should involve in “the transgenic “Embrapa 5.1” common bean for golden mosaic virus (BGMV) resistance”. In my opinion, the manuscript could not be accepted for publication in the present form.

1. The quality of photos (Fig.2-Fig.5, Fig. 7) is not high enough, and the label obscures the image, please replace.

2. The marker can't see at all in Fig.6, why? Please replace.

3. Line 37 “This is the first stable transgenic common bean”. If you have authentic proofs please provide that. Otherwise rewrite.

4. Check the small errors in the whole manuscript (for example: Line 50 “by”, Line 93 “, and”).

5. The first abbreviation shall provide the full name. For example, Line 173 “CTAB”.

6. Figure caption and citations should be referred to Plos one instruction.

Reviewer #2: The have developed an Agrobacterium-mediated transformation protocol for Phaseolus vulgaris. Although more efficient and less time-consuming approach for Phaseolus agrobacterial transformation already exist (Collado et al., 2015), this work is worth publishing, because it presents an alternative way that might serve for gene delivery to recalcitrant Phaseolus genotypes. In general, the manuscript is well written, concise and straightforward. In my opinion this manuscript can be accepted for publishing after the authors will revise/explain following issues:

1. Authors refer to picture 7A, B or C but nothing like these letters is presented in picture 7.

2. Line 293 - authors claim that T1 plants were subjected to both PCR and RT-PCR. I could not find any output of PCR analysis - it is not clear from text whether the PCR results where similar to RT-PCR or why do authors not present them in any table or image. Moreover, when presenting the RT-PCR results, the authors should show also the results of RT- (non-reverse transcribed) reaction to exclude the amplification from not properly removed genomic DNA (especially when the amplicon does not contain the intron).

3. Line 316 - authors claim that an integration of non-T-DNA fragment occured in T1 plants. I wonder how this can happen, despite the fact, that T1 generation plants were not subjected to Agrobacterium transformation.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: Yes: Vojtech Hudzieczek

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step.

Decision Letter 1

Jen-Tsung Chen

19 Feb 2020

Induction of competent cells for Agrobacterium tumefaciens-mediated stable transformation of common bean (Phaseolus vulgaris L.)

PONE-D-19-35407R1

Dear Dr. Song,

We are pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it complies with all outstanding technical requirements.

Within one week, you will receive an e-mail containing information on the amendments required prior to publication. When all required modifications have been addressed, you will receive a formal acceptance letter and your manuscript will proceed to our production department and be scheduled for publication.

Shortly after the formal acceptance letter is sent, an invoice for payment will follow. To ensure an efficient production and billing process, please log into Editorial Manager at https://www.editorialmanager.com/pone/, click the "Update My Information" link at the top of the page, and update your user information. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, you must inform our press team as soon as possible and no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

With kind regards,

Jen-Tsung Chen, Ph.D.

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Acceptance letter

Jen-Tsung Chen

21 Feb 2020

PONE-D-19-35407R1

Induction of competent cells for Agrobacterium tumefaciens-mediated stable transformation of common bean (Phaseolus vulgaris L.)

Dear Dr. Song:

I am pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

For any other questions or concerns, please email plosone@plos.org.

Thank you for submitting your work to PLOS ONE.

With kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Jen-Tsung Chen

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Table. Identification of transgene inserts using 35S-bar as a query BLASTN against the assembled genome of the T0 plant of transgenic line #1.

    (XLSX)

    S1 Fig

    (TIF)

    Attachment

    Submitted filename: PONE-D-19-35407-review comments.docx

    Data Availability Statement

    All relevant data are within the paper and its Supporting Information files.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES